Back to Search
GERALD DURKAN, MD
MD
General Practice Physician
NPI: 1831689793Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (7)
Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.
PMID 12855633·Clin Cancer Res·2003
8-other
Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
PMID 11705862·Clin Cancer Res·2001
8-other
Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine.
PMID 12614260·BJU Int·2003
8-other
Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer.
PMID 11857492·J Pathol·2002
8-other
Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol.
PMID 11849157·BJU Int·2002
8-other
Caveolin-1 expression is associated with high-grade bladder cancer.
PMID 11711373·Urology·2001
8-other
Diagnostic dilemmas in detection of prostate cancer in patients undergoing transrectal ultrasound-guided needle biopsy of the prostate.
PMID 12497156·Prostate Cancer Prostatic Dis·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 8901 Wisconsin Avenue Transitional Year Program
Bethesda, MD 20889 - Phone
- (301) 295-9283
Quick Facts
- NPI
- 1831689793
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 3
- Publications
- 7
Are you this provider?
Claim Your Profile